1. Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study. (February 2021) Authors: de Marinis, Filippo; Laktionov, Konstantin K.; Poltoratskiy, Artem; Egorova, Inna; Hochmair, Maximilian; Passaro, Antonio; Migliorino, Maria Rita; Metro, Giulio; Gottfried, Maya; Tsoi, Daphne; Ostoros, Gyula; Rizzato, Simona; Mukhametshina, Guzel Z.; Schumacher, Michael; Novello, Silvia; Dziadziu... Journal: Lung cancer Issue: Volume 152(2021) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients. Issue 4 (November 2018) Authors: Metro, Giulio; Giannarelli, Diana; Sidoni, Angelo; Chiari, Rita; Bellezza, Guido Journal: International journal of biological markers Issue: Volume 33:Issue 4(2018) Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Beyond EGFR and ALK inhibition: Unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer. Issue 5 (May 2015) Authors: Califano, Raffaele; Abidin, Aidalena; Tariq, Noor-ul-Ain; Economopoulou, Panagiota; Metro, Giulio; Mountzios, Giannis Journal: Cancer treatment reviews Issue: Volume 41:Issue 5(2015) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. (February 2018) Authors: Metro, Giulio; Passaro, Antonio; Lo Russo, Giuseppe; Bonanno, Laura; Giusti, Raffaele; Gregorc, Vanesa; Capelletto, Enrica; Martelli, Olga; Cecere, Fabiana L; Giannarelli, Diana; Luciani, Andrea; Bearz, Alessandra; Tuzi, Alessandro; Scotti, Vieri; Tonini, Giuseppe; Galetta, Domenico; Carta, Annam... Journal: Future oncology Issue: Volume 14:Number 4(2018) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis. Issue 2 (November 2015) Authors: Chiari, Rita; Metro, Giulio; Iacono, Daniela; Bellezza, Guido; Rebonato, Alberto; Dubini, Alessandra; Sperduti, Isabella; Bennati, Chiara; Paglialunga, Luca; Burgio, Marco Angelo; Baglivo, Sara; Giusti, Raffaele; Minotti, Vincenzo; Delmonte, Angelo; Crinò, Lucio Journal: Lung cancer Issue: Volume 90:Issue 2(2015:Nov.) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Corrigendum to "Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC" [Cancer Treat. Rev. 104 (2022) 102350]. (March 2022) Authors: Friedlaender, Alex; Naidoo, Jarushka; Luigi Banna, Giuseppe; Metro, Giulio; Forde, Patrick; Addeo, Alfredo Journal: Cancer treatment reviews Issue: Volume 104(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CSF Concentration of Crizotinib in Two ALK-Positive Non–Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment. Issue 5 (May 2015) Authors: Metro, Giulio; Lunardi, Gianluigi; Floridi, Piero; Pascali, Jennifer P.; Marcomigni, Luca; Chiari, Rita; Ludovini, Vienna; Crinò, Lucio; Gori, Stefania Journal: Journal of thoracic oncology Issue: Volume 10:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CSF Concentration of Crizotinib in Two ALK-Positive Non–Small-Cell Lung Cancer Patients with CNS Metastases Deriving Clinical Benefit from Treatment. Issue 5 (May 2015) Authors: Metro, Giulio; Lunardi, Gianluigi; Floridi, Piero; Pascali, Jennifer P.; Marcomigni, Luca; Chiari, Rita; Ludovini, Vienna; Crinò, Lucio; Gori, Stefania Journal: Journal of thoracic oncology Issue: Volume 10:Issue 5(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. Issue 4 (7th April 2021) Authors: Cortellini, Alessio; Di Maio, Massimo; Nigro, Olga; Leonetti, Alessandro; Cortinovis, Diego L; Aerts, Joachim GJV; Guaitoli, Giorgia; Barbieri, Fausto; Giusti, Raffaele; Ferrara, Miriam G; Bria, Emilio; D'Argento, Ettore; Grossi, Francesco; Rijavec, Erika; Guida, Annalisa; Berardi, Rossana; Torni... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non–Small Cell Lung Cancer With a PD-L1 Expression ≥50%. Issue 9 (November 2020) Authors: Metro, Giulio; Banna, Giuseppe Luigi; Signorelli, Diego; Gili, Alessio; Galetta, Domenico; Galli, Giulia; Economopoulou, Panagiota; Roila, Fausto; Friedlaender, Alex; Camerini, Andrea; Christopoulou, Athina; Cantale, Ornella; De Toma, Alessandro; Pizzutilo, Pamela; Jimenez, Beatriz; Collazo-Lordu... Journal: Journal of immunotherapy Issue: Volume 43:Issue 9(2020:Nov./Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗